IGM Financial Inc. (IGM.TO) (TSE:IGM) Cut to “Hold” at Desjardins

IGM Financial Inc. (IGM.TO) (TSE:IGM) was downgraded by investment analysts at Desjardins from a “buy” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. Desjardins also issued estimates for IGM Financial Inc. (IGM.TO)’s Q4 2020 earnings at $0.91 EPS, FY2020 earnings at $3.25 EPS, Q1 2021 earnings at $0.85 EPS, Q2 […] Skip to content News explorer – Search Regulatory news, RNS Search, via Company or code, Index, Industry Sector, Headline type, Release date and Source

IGM Financial Inc. (IGM.TO) (TSE:IGM) was downgraded by investment analysts at Desjardins from a “buy” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. Desjardins also issued estimates for IGM Financial Inc. (IGM.TO)’s Q4 2020 earnings at $0.91 EPS, FY2020 earnings at $3.25 EPS, Q1 2021 earnings at $0.85 EPS, Q2 2021 earnings at $0.94 EPS, Q3 2021 earnings at $0.99 EPS, Q4 2021 earnings at $0.92 EPS, FY2021 earnings at $3.83 EPS and FY2022 earnings at $4.01 EPS.

Several other analysts also recently issued reports on the company. Scotiabank raised their price target on IGM Financial Inc. (IGM.TO) from C$38.00 to C$40.00 in a report on Tuesday, February 2nd. Canaccord Genuity raised their price target on IGM Financial Inc. (IGM.TO) from C$36.50 to C$38.00 and gave the stock a “buy” rating in a report on Wednesday, February 3rd. TD Securities raised their price target on IGM Financial Inc. (IGM.TO) from C$33.00 to C$34.00 and gave the stock a “hold” rating in a report on Monday, November 9th. Finally, BMO Capital Markets downgraded IGM Financial Inc. (IGM.TO) from an “outperform” rating to a “market perform” rating and set a C$33.00 price target on the stock. in a report on Monday, January 25th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of C$37.83.

TSE:IGM opened at C$34.85 on Friday. The company has a quick ratio of 0.70, a current ratio of 3.23 and a debt-to-equity ratio of 44.94. The business’s 50 day moving average is C$35.24 and its two-hundred day moving average is C$33.36. IGM Financial Inc. has a 52 week low of C$20.96 and a 52 week high of C$40.38. The company has a market cap of C$8.31 billion and a PE ratio of 11.43.

IGM Financial Inc. (IGM.TO) Company Profile

IGM Financial Inc operates as a wealth and asset management company in Canada. It operates through IG Wealth Management, Mackenzie Investments, and Corporate and Other segments. The company also offers financial planning services, including investment, tax, retirement, education, risk management, and estate planning; strategic investment planning tools; mutual funds; iProfile, a portfolio management program; and separately managed accounts and fee-based brokerage accounts.

Recommended Story: How interest rates affect municipal bond prices

Receive News & Ratings for IGM Financial Inc. (IGM.TO) Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for IGM Financial Inc. (IGM.TO) and related companies with MarketBeat.com’s FREE daily email newsletter.

Paycom Software, Inc. (NYSE:PAYC) Stock Position Raised by State of Wisconsin Investment Board

Kinsale Capital Group, Inc. (NASDAQ:KNSL) Increases Dividend to $0.11 Per Share

Source: www.americanbankingnews.com

Author: ABMN Staff

Recent Stock News: NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) – Article Update

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM), closed the day at $29.17, a rise of 0.55 per cent and a stock price that brought its market cap to $2.23 billion. The outstanding share count is 68.82 million shares but the size of available float is 50.63 million shares. The stock’s current price is trailing SMA-200 by 37.47% which is also 6.48% up from SMA-50. Reducing that period to a shorter term, we see the price is trailing 7.58% to the SMA-20. Volatility for the week was 5.71%, which was 5.99% in the previous month.

The company closed the session with a trading volume of 134.97 thousand shares, below from its average daily trading volume of 274.37 thousand. It has been generating revenue of $98.7 million while net income posted by the company in last 12 months was -$90.4 million. When looking at performance, we see the stock demonstrating a weekly performance of 9.33% while keeping a monthly performance of 13.5%. Quarterly performance saw a rise of 53.61% but succeeded to record a yearly performance of 80.17% while showing YTD performance of -3.71% which was 62.87% for last six months.

The 52-week range for the stock was 9.24 – 32.05 that put its current price at a premium of 215.52% to the 52-week low price whereas it is trading at a discount of -8.99% to the 52-week high price. The Biotechnology company is currently upholding a gross margin of 0% while maintaining a net profit margin of -91.6%. Operating margin for the last 12 months remained -94.6%.

The company’s EPS for trailing 12 months is -$1.33 and its annual dividend yield is 0% with a payout ratio of 0%. It is estimated to be posting an EPS of -$0.47 for the current quarter. The Beta number showed the stock is subject to risk -100% less than the market as a whole. In the trailing twelve months, its return on assets (ROA) is -25.6% while ROE for the same period is -29.5% and have seen an average of -14.9% return on investment (ROI).

Source: articleupdate.com

Author: Brian C Lorenz

News by ABERDEEN JAPAN INVESTMENT TRUST PLC Company or code – between 14 November 2020 and 14 February 2021 Time period News explorer

11 February 2021